Hepatitis Monthly

Published by: Kowsar

Occult Hepatitis C Virus Infection in Candidates for Liver Transplant With Cryptogenic Cirrhosis

Hossein Keyvani 1 , Farah Bokharaei-Salim 1 , * , Seyed Hamidreza Monavari 2 , Maryam Esghaei 1 , Mohssen Nassiri Toosi 3 , Shahin Fakhim 4 , Zohreh-Azita Sadigh 5 and Seyed Moayed Alavian 6
Authors Information
1 Department of Virology, Iran University of Medical Sciences, Tehran, IR Iran
2 Department of Virology and Anti-Microbial Resistant Research Center, Iran University of Medical Sciences, Tehran, IR Iran
3 Department of Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
4 Department of Civil Engineering, Islamic Azad University, Shahre Qods, Tehran, IR Iran
5 Razi Vaccine and Serum Research Institute, Karaj, IR Iran
6 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Tehran, IR Iran
Article information
  • Hepatitis Monthly: August 01, 2013, 13 (8); e11290
  • Published Online: August 5, 2013
  • Article Type: Research Article
  • Received: March 23, 2013
  • Revised: June 27, 2013
  • Accepted: July 3, 2013
  • DOI: 10.5812/hepatmon.11290

To Cite: Keyvani H, Bokharaei-Salim F, Monavari S H, Esghaei M, Nassiri Toosi M, et al. Occult Hepatitis C Virus Infection in Candidates for Liver Transplant With Cryptogenic Cirrhosis, Hepat Mon. 2013 ; 13(8):e11290. doi: 10.5812/hepatmon.11290.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ. 1977; 55(4): 521-40[PubMed]
  • 2. Czaja AJ. Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults. Dig Dis Sci. 2011; [DOI][PubMed]
  • 3. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999; 29(3): 664-9[DOI][PubMed]
  • 4. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology. 2009; 49(3): 1017-44[DOI][PubMed]
  • 5. Saunders JB, Walters JR, Davies AP, Paton A. A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed). 1981; 282(6260): 263-6[PubMed]
  • 6. Belle SH, Beringer KC, Detre KM. An update on liver transplantation in the United States: recipient characteristics and outcome. Clin Transpl. 1995; : 19-33[PubMed]
  • 7. Charlton MR, Kondo M, Roberts SK, Steers JL, Krom RA, Wiesner RH. Liver transplantation for cryptogenic cirrhosis. Liver Transpl Surg. 1997; 3(4): 359-64[PubMed]
  • 8. Desai HG. Cryptogenic cirrhosis: a vanishing entity. J Assoc Physicians India. 2009; 57: 751-4[PubMed]
  • 9. Al-Mahtab M, Rahman S, Khan M. Occult Hepatitis B Virus Related Decompensated Cirrhosis of Liver in Young Males: First Report of Two Cases from Bangladesh. Hepatitis Monthly. 2008; 8(2): 147-50
  • 10. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004; 44(1): 20-9[DOI][PubMed]
  • 11. Alavian SM, Ahmadzad-Asl M, Lankarani KB, Shahbabaie MA, Bahrami Ahmadi A, Kabir A. Hepatitis C Infection in the General Population of Iran: A Systematic Review. Hepat Mon. 2009; 9(3): 211-23
  • 12. Pham TN, Michalak TI. Occult persistence and lymphotropism of hepatitis C virus infection. World J Gastroenterol. 2008; 14(18): 2789-93[PubMed]
  • 13. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis. 2004; 189(1): 7-14[DOI][PubMed]
  • 14. Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012; 18(23): 2887-94[DOI][PubMed]
  • 15. Bokharaei Salim F, Keyvani H, Amiri A, Jahanbakhsh Sefidi F, Shakeri R, Zamani F. Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection. World J Gastroenterol. 2010; 16(16): 2005-9[PubMed]
  • 16. Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia-Fernandez N, et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol. 2008; 19(12): 2288-92[DOI][PubMed]
  • 17. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011; 83(6): 989-95[DOI][PubMed]
  • 18. Farahani M, Bokharaei-Salim F, Ghane M, Basi A, Meysami P, Keyvani H. Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders. J Med Virol. 2013; 85(2): 235-40[DOI][PubMed]
  • 19. Schiano TD, Martin P. Management of HCV infection and liver transplantation. Int J Med Sci. 2006; 3(2): 79-83[PubMed]
  • 20. Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest. 2010; 39(3): 284-91[DOI][PubMed]
  • 21. Idrees M, Lal A, Malik FA, Hussain A, Rehman I, Akbar H, et al. Occult hepatitis C virus infection and associated predictive factors: the Pakistan experience. Infect Genet Evol. 2011; 11(2): 442-5[DOI][PubMed]
  • 22. Comar M, Dal Molin G, D'Agaro P, Croce SL, Tiribelli C, Campello C. HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers. J Clin Pathol. 2006; 59(5): 526-9[DOI][PubMed]
  • 23. De Marco L, Gillio-Tos A, Fiano V, Ronco G, Krogh V, Palli D, et al. Occult HCV infection: an unexpected finding in a population unselected for hepatic disease. PLoS One. 2009; 4(12)[DOI][PubMed]
  • 24. De Marco L, Manzini P, Trevisan M, Gillio-Tos A, Danielle F, Balloco C, et al. Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease. PLoS One. 2012; 7(8)[DOI][PubMed]
  • 25. Giannini C, Giannelli F, Zignego AL. Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology. 2006; 43(5): 1166-7[DOI][PubMed]
  • 26. Richiardi L, De Marco L, Gillio-Tos A, Merletti F, Fiano V, Palli D, et al. Persistent infection by HCV and EBV in peripheral blood mononuclear cells and risk of non-Hodgkin's lymphoma. Cancer Epidemiol. 2010; 34(6): 709-12[DOI][PubMed]
  • 27. Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology. 2009; 49(2): 665-75[DOI][PubMed]
  • 28. Sefidi FJ, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of Hepatitis C Virus Genotypes in Iranian Chronic Infected Patients. Hepatitis Monthly. 2013; 13(1)
  • 29. Stramer SL. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med. 2007; 131(5): 702-7[PubMed]
  • 30. Alavian SM, Gholami B, Masarrat S. Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol. 2002; 17(10): 1092-7[PubMed]
  • 31. Falagas ME, Karydis I, Kostogiannou I. Percutaneous exposure incidents of the health care personnel in a newly founded tertiary hospital: a prospective study. PLoS One. 2007; 2(2)[DOI][PubMed]
  • 32. Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V. Hepatitis C virus infection in the family setting of patients with occult hepatitis C. J Med Virol. 2009; 81(7): 1198-203[DOI][PubMed]
  • 33. Melon S, Galarraga MC, Villar M, Laures A, Boga JA, de Ona M, et al. Hepatitis C virus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transplant Proc. 2005; 37(5): 2083-5[DOI][PubMed]
  • 34. Cortés-Mancera FM, Restrepo JC, Osorio G, Hoyos S, Correa G, MC N. Occult hepatitis C virus infection in a retransplanted patients with liver failure of unknown etiology. Rev Col Gastroenterol. 2010; 25: 72-80
  • 35. Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol. 2003; 41(7): 3212-20[PubMed]
  • 36. Stankovi -Djordjevi D, Tasi G, Dini M, Miladinovi -Tasi N, Stojanovi P, Bogdanovi M. Hepatitis C virus (HCV) viremia in patients with indeterminate second-generation HCV recombinant immunoblot assay. 2007;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments